SCHEMBL19791975

SCHEMBL19791975

Cc1ccc2c(c1)C(N)CCN2C(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.47
GPR119 Q8TDV5 4/20 0.43
LMNA P02545 3/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
KDM4E B2RXH2 1/20 0.40
AADAT Q8N5Z0 1/20 0.39
EPHX2 P34913 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
MAPT P10636 1/20 0.37
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15686278 0.86 KDM1A (0.46) KDM1AGPR119LMNAKMT2AMEN1
SCHEMBL15686279 0.84 KDM1A (0.45) KDM1AGPR119KMT2AMEN1AADAT
SCHEMBL26090253 0.83 KDM1A (0.59) KDM1AGPR119KMT2AMEN1KDM4E
SCHEMBL30346003 0.83 KDM1A (0.59) KDM1AGPR119KMT2AMEN1KDM4E
SCHEMBL1985926 0.83 KDM1A (0.59) KDM1AGPR119KMT2AMEN1KDM4E
Trifluoroacetic Acid SCHEMBL18783557 0.82 KDM1A (0.43) KDM1AGPR119KMT2AMEN1MAPT
SCHEMBL19893422 0.79 KDM1A (0.46) KDM1ANPSR1KMT2AMEN1AADAT
Hydrochloric Acid SCHEMBL20262215 0.78 KDM1A (0.46) KDM1ANPSR1KMT2AMEN1MAPT
SCHEMBL22868107 0.77 SMN1; SMN2 (0.45) LMNANPSR1KMT2AMEN1MAPT
SCHEMBL8399608 0.76 GPR119 (0.43) KDM1AGPR119LMNANPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3272749-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE Bayer Pharma Aktiengesellschaft (DE) 2018-01-24 EP disclosed